{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:18:56Z","timestamp":1789917536155,"version":"4.0.1"},"reference-count":26,"publisher":"Bentham Science Publishers Ltd.","issue":"1","license":[{"start":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T00:00:00Z","timestamp":1535673600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"content-domain":{"domain":["openmicrobiologyjournal.com","benthamopen.com"],"crossmark-restriction":true},"short-container-title":["TOMICROJ"],"published-print":{"date-parts":[[2018,8,31]]},"abstract":"<jats:sec><jats:title>Introduction:<\/jats:title><jats:p>Multiple-drug resistant bacteria are emerging exponentially in healthcare units, threatening public health and requiring novel therapeutic approaches. In 2017, World Health Organization published a list that frames antimicrobial resistant bacteria into priority levels for research of novel drugs to fight them.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods &amp; Materials:<\/jats:title><jats:p>Antimicrobial resistant ESKAPE (<jats:italic>Enterococcus faecium<\/jats:italic>,<jats:italic>Staphylococcus aureus<\/jats:italic>,<jats:italic>Klebsiella pneumoniae<\/jats:italic>,<jats:italic>Acinetobacter baumannii<\/jats:italic>,<jats:italic>Pseudomonas aeruginosa<\/jats:italic>,<jats:italic>Enterobacter<\/jats:italic>sp.) and<jats:italic>Enterococcus faecalis<\/jats:italic>and<jats:italic>Escherichia coli<\/jats:italic>pathogens are present in this list. Representative isolates of each species were used to test the Antibacterial and anti-biofilm formation activities of Etodolac (a Non-Steroidal Anti-Inflammatory Drug, NSAID) at 10 and 1 mM using a broth microdilution technique.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results &amp; Discussion:<\/jats:title><jats:p>Statistically significant (p&lt; 0,05) results were observed against all tested gram-positives, particularly anti-biofilm activity against<jats:italic>E. faecium<\/jats:italic>. Etodolac had an almost null influence on tested gram-negatives, with the exception of one<jats:italic>A. baumannii<\/jats:italic>clinical isolate regarding biofilm formation inhibition. Observed differences deserve further analysis and prospection of the involved mechanisms, to unravel possible novel bacterial targets for drug development. Similar work with other NSAID\u2019s may also be worth exploring to ascertain novel therapeutic applications for these drugs, particularly regarding biofilm formation inhibition,<jats:italic>per si<\/jats:italic>or as adjuvants of current antibiotherapy, mainly against gram-positives, as suggested by present work.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Already approved drugs in terms of pharmacokinetics and safety may deploy faster solutions for antimicrobial therapy against priority pathogens. Current work intends to bring attention to that possibility, particularly regarding NSAIDs, anti-biofilm formation and top priority pathogens.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1874285801812010288","type":"journal-article","created":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T05:53:07Z","timestamp":1536817987000},"page":"288-296","update-policy":"https:\/\/doi.org\/10.2174\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Non-Antimicrobial Drugs: Etodolac as a Possible Antimicrobial or Adjuvant Agent Against ESKAPE Pathogens"],"prefix":"10.2174","volume":"12","author":[{"given":"S\u00f3nia G.","family":"Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa S.","family":"Domingues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Theri\u00e1ga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria de Jesus","family":"Chasqueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo","family":"Paix\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref1","first-page":"56","volume":"14","author":"Adedeji W.A.","year":"2016","unstructured":"Adedeji WA. The treasure called antibiotics. Ann Ib Postgrad Med 2016; 14 (2) : 56-7.","journal-title":"Ann. Ib. Postgrad. Med."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1089\/mdr.2014.0137","volume":"21","author":"Pereira S.G.","year":"2015","unstructured":"Pereira SG, Marques M, Pereira J, Cardoso O. Multidrug and extensive drug resistance in Pseudomonas aeruginosa clinical isolates from a Portuguese central hospital: 10-year survey. Microb Drug Resist 2015; 21 (2) : 194-200.","journal-title":"Microb. Drug Resist."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1586\/eri.13.12","volume":"11","author":"Pendleton J.N.","year":"2013","unstructured":"Pendleton JN, Gorman SP, Gilmore BF. Clinical relevance of the ESKAPE pathogens. Expert Rev Anti Infect Ther 2013; 11 (3) : 297-308.","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"ref4","unstructured":"World Health Organization. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics 2017. http:\/\/www.who.int\/medicines\/publications\/ global-priority-list-antibiotic- resistant-bacteria\/en\/ accessed on March 24th, 2018"},{"key":"ref5","first-page":"7","volume":"30","author":"Kristiansen J.E.","year":"1992","unstructured":"Kristiansen JE. The antimicrobial activity of non-antibiotics. Report from a congress on the antimicrobial effect of drugs other than antibiotics on bacteria, viruses, protozoa, and other organisms. APMIS Suppl 1992; 30 (Suppl. 30) : 7-14.","journal-title":"APMIS Suppl."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s10096-009-0739-z","volume":"28","author":"Mazumdar K.","year":"2009","unstructured":"Mazumdar K, Dastidar SG, Park JH, Dutta NK. The anti-inflammatory non-antibiotic helper compound diclofenac: An antibacterial drug target. Eur J Clin Microbiol Infect Dis 2009; 28 (8) : 881-91.","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref7","first-page":"233","volume":"89","author":"Chakrabarty A.N.","year":"1989","unstructured":"Chakrabarty AN, Acharya DP, Neogi D, Dastidar SG. Drug interaction of promethazine & other non-conventional antimicrobial chemotherapeutic agents. Indian J Med Res 1989; 89 : 233-7.","journal-title":"Indian J. Med. Res."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.micres.2004.10.002","volume":"160","author":"Rani Basu L.","year":"2005","unstructured":"Rani Basu L, Mazumdar K, Dutta NK, Karak P, Dastidar SG. Antibacterial property of the antipsychotic agent prochlorperazine, and its synergism with methdilazine. Microbiol Res 2005; 160 (1) : 95-100.","journal-title":"Microbiol. Res."},{"key":"ref9","first-page":"506","volume":"87","author":"Dastidar S.G.","year":"1988","unstructured":"Dastidar SG, Das S, Mookerjee M, Chattopadhyay D, Ray S, Chakrabarty AN. Antibacterial activity of local anaesthetics procaine & lignocaine. Indian J Med Res 1988; 87 : 506-8.","journal-title":"Indian J. Med. Res."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0255-0857(21)03067-X","volume":"21","author":"Sarkar A.","year":"2003","unstructured":"Sarkar A, Kumar KA, Dutta NK, Chakraborty P, Dastidar SG. Evaluation of in vitro and in vivo antibacterial activity of dobutamine hydrochloride. Indian J Med Microbiol 2003; 21 (3) : 172-8.","journal-title":"Indian J. Med. Microbiol."},{"key":"ref11","first-page":"CD008872","author":"Colebatch A.N.","year":"2011","unstructured":"Colebatch AN, Marks JL, Edwards CJ. Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis). Cochrane Database Syst Rev 2011; (11): CD008872.","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref12","first-page":"CD007357","author":"Tirunagari S.K.","year":"2009","unstructured":"Tirunagari SK, Derry S, Moore RA, McQuay HJ. Single dose oral etodolac for acute postoperative pain in adults. Cochrane Database Syst Rev 2009; (3): CD007357.","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref13","unstructured":"Alkuraishy HM. Antibacterial action of discriminating cyclooxygenase-2 inhibitors: In vitro study: Consideration and appraisal. WebmedCentral: Journal of Clinical research and healthcare management 2012. 3: WMC002976"},{"key":"ref14","first-page":"532","volume":"3","author":"Mishra D.","year":"2010","unstructured":"Mishra D, Kumar PS, Panda PK. Evaluation of antimicrobial activity of selective COX-2 inhibitor. Rasayan J Chem 2010; 3 : 532-8.","journal-title":"Rasayan J. Chem."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1086\/533452","volume":"197","author":"Rice L.B.","year":"2008","unstructured":"Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE. J Infect Dis 2008; 197 (8) : 1079-81.","journal-title":"J. Infect. Dis."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.4155\/fmc.15.6","volume":"7","author":"Rabin N.","year":"2015","unstructured":"Rabin N, Zheng Y, Opoku-Temeng C, Du Y, Bonsu E, Sintim HO. Biofilm formation mechanisms and targets for developing antibiofilm agents. Future Med Chem 2015; 7 (4) : 493-512.","journal-title":"Future Med. Chem."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1111\/jam.12463","volume":"116","author":"Pereira S.G.","year":"2014","unstructured":"Pereira SG, Rosa AC, Ferreira AS, et al. Virulence factors and infection ability of Pseudomonas aeruginosa isolates from a hydropathic facility and respiratory infections. J Appl Microbiol 2014; 116 (5) : 1359-68.","journal-title":"J. Appl. Microbiol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e1002184","DOI":"10.1371\/journal.pmed.1002184","volume":"13","author":"de Kraker M.E.A.","year":"2016","unstructured":"de Kraker MEA, Stewardson AJ, Harbarth S. Will 10 million people die a year due to antimicrobial resistance by 2050? PLoS Med 2016; 13 (11) : e1002184.","journal-title":"PLoS Med."},{"key":"ref19","first-page":"7332","volume":"8","author":"Umaru T.","year":"2009","unstructured":"Umaru T, Neamba CO, Kolo I, Nwodo U. Antimicrobial activity of non-steroidal anti-inflammatory drugs with respect to immunological response: Diclofenac sodium as a case study. Afr J Biotechnol 2009; 8 : 7332-9.","journal-title":"Afr. J. Biotechnol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/1758-2229.12346","volume":"7","author":"Bucher T.","year":"2015","unstructured":"Bucher T, Oppenheimer-Shaanan Y, Savidor A, Bloom-Ackermann Z, Kolodkin-Gal I. Disturbance of the bacterial cell wall specifically interferes with biofilm formation. Environ Microbiol Rep 2015; 7 (6) : 990-1004.","journal-title":"Environ. Microbiol. Rep."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2174\/1874285801711010053","volume":"11","author":"Singh S.","year":"2017","unstructured":"Singh S, Singh SK, Chowdhury I, Singh R. Understanding the mechanism of bacterial biofilms resistance to antimicrobial agents. Open Microbiol J 2017; 11 : 53-62.","journal-title":"Open Microbiol. J."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/anr.1780320102","volume":"32","author":"Abramson S.B.","year":"1989","unstructured":"Abramson SB, Weissmann G. The mechanisms of action of nonsteroidal antiinflammatory drugs. Arthritis Rheum 1989; 32 (1) : 1-9.","journal-title":"Arthritis Rheum."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1128\/MMBR.67.4.593-656.2003","volume":"67","author":"Nikaido H.","year":"2003","unstructured":"Nikaido H. Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev 2003; 67 (4) : 593-656.","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s11908-014-0431-z","volume":"16","author":"Nigo M.","year":"2014","unstructured":"Nigo M, Munita JM, Arias CA, Murray BE. What\u2019s new in the treatment of enterococcal endocarditis? Curr Infect Dis Rep 2014; 16 (10) : 431.","journal-title":"Curr. Infect. Dis. Rep."},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Schroeder M, Brooks BD, Brooks AE. The complex relationship between virulence and antibiotic resistance genes. Basel 2017; 8 (39)","DOI":"10.3390\/genes8010039"},{"key":"ref26","first-page":"36","volume":"3","author":"van Tilburg Bernardes E.","year":"2015","unstructured":"van Tilburg Bernardes E, Lewenza S, Reckseidler-Zenteno S. Current research approaches to target biofilm infections. Postdoc J 2015; 3 (6) : 36-49.","journal-title":"Postdoc J."}],"container-title":["The Open Microbiology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/openmicrobiologyjournal.com\/contents\/volumes\/V12\/TOMICROJ-12-288\/TOMICROJ-12-288.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/openmicrobiologyjournal.com\/contents\/volumes\/V12\/TOMICROJ-12-288\/TOMICROJ-12-288.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/openmicrobiologyjournal.com\/contents\/volumes\/V12\/TOMICROJ-12-288\/TOMICROJ-12-288.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T06:47:41Z","timestamp":1662014861000},"score":1,"resource":{"primary":{"URL":"https:\/\/openmicrobiologyjournal.com\/VOLUME\/12\/PAGE\/288\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,31]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,8,31]]}},"alternative-id":["TOMICROJ-12-288"],"URL":"https:\/\/doi.org\/10.2174\/1874285801812010288","relation":{},"ISSN":["1874-2858"],"issn-type":[{"value":"1874-2858","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8,31]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-5-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-8-5","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-8-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}